Assetmark »

Fulcrum Therapeutics shares owned by Assetmark

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Assetmark

Quarter filed Position value Share count Share price at filing
2025-09-30 $88k 9.6k 9.20

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Proshares Tr Pshs Ult S&p 500 (SSO)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Tr Iboxx Hi Yd Etf (HYG)

View all positions for Assetmark

Top funds holding Fulcrum Therapeutics

RA Capital Management
Suvretta Capital Management
TCG Crossover Management
Nantahala Capital Management
BlackRock
Vanguard Group
Adage Capital Partners GP
Balyasny Asset Management
D. E. Shaw & Co
Dimensional Fund Advisors
Ikarian Capital
State Street Corporation
Geode Capital Management
Royal Bank of Canada
Citadel Advisors

View all funds holding Fulcrum Therapeutics